http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101631589-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-322 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-357 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-83 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357 |
| filingDate | 2011-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101631589-B1 |
| titleOfInvention | Pharmaceutical composition for preventing or treating neurodegenerative diseases comprising compounds isolated from Daphne genkwa extract |
| abstract | The present invention relates to a pharmaceutical composition for preventing or treating neurodegenerative diseases comprising, as an active ingredient, Genkwanine N or Yuanhuacine, or a pharmaceutically acceptable salt thereof, . More particularly, the present invention relates to a pharmaceutical composition for preventing or treating neurodegenerative diseases comprising Genkwanine N or Yuanhuacine, or a pharmaceutically acceptable salt thereof, isolated from an organic solvent extract of Red Bean Blossom as an active ingredient, a pharmaceutical composition for treating Nurr1 dysfunction , A Nurr1 activating composition, and a functional food additive for preventing or ameliorating a neurodegenerative disease comprising Genkwanine N or Yuanhuacine as an active ingredient. The compound of the present invention isolated from the red bean curd extract has excellent effects in restoring the inhibition of Nurr1 protein activity due to nerve damage without showing any side effects as a natural product compound. Thus, it is possible to prevent Parkinson's disease caused by inhibition of Nurr1 protein activity Can be prevented or treated. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3539550-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10792323-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018088862-A1 |
| priorityDate | 2011-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 184.